Can Comprehensive Genomic Profiling change the game?
It was my great pleasure to team up with t Ayse Levent , Ipsos' Molecular Diagnostic expert, to bring you this point of view exploring how treatment for Non Small Cell Lung Cancer is being impacted by the approval of new targeted therapies, as well as the increased use of Comprehensive Genomic Profiling. This is great for patients, but we can (and will!) do better!
Read the full details and download the PDF at: